Showing results (1201-1210 of 1,301) with videos related to

Sort By:
Pageof 131
JAMA Cardiology|August 4, 2021
Blood DNA Methylation and Incident Coronary Heart Disease: Evidence From the Strong Heart StudyAna Navas-Acien, Arce Domingo-Relloso, Pooja Subedi, et al.
JAMA Cardiology|March 15, 2023
State-Level Cardiovascular Mortality Rates Among Hispanic, Non-Hispanic Black, and Non-Hispanic White Populations, 1990 to 2019Catherine O Johnson, Nicole K DeCleene, Brigette F Blacker, et al.
JAMA Cardiology|March 8, 2023
Effect of Sacubitril/Valsartan vs Valsartan on Left Atrial Volume in Patients With Pre-Heart Failure With Preserved Ejection Fraction: The PARABLE Randomized Clinical TrialMark Ledwidge, Jonathan D Dodd, Fiona Ryan, et al.
JAMA Cardiology|November 12, 2025
Major Bleeding With Apixaban vs Aspirin: A Subanalysis of the ARTESiA Randomized Clinical TrialDeborah M Siegal, Christian Sticherling, Jeff S Healey, et al.
JAMA Cardiology|December 23, 2025
Polygenic Background and Penetrance of Pathogenic Variants in Hypertrophic and Dilated CardiomyopathiesSarah A Abramowitz, Lily Hoffman-Andrews, David Zhang, et al.
JAMA Cardiology|October 8, 2025
Intracardiac vs Transesophageal Echocardiography in Atrial Fibrillation Ablation: A Randomized Clinical TrialXiaofeng Hu, Weifeng Jiang, Xinhua Wang, et al.
JAMA Cardiology|October 8, 2025
Contributions of Common, Rare, and Somatic Genetic Variants to Incidence of Atrial FibrillationRufan Zhang, Min Seo Kim, Wanqing Yin, et al.
JAMA Cardiology|April 24, 2020
Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, ChinaJuyi Li, Xiufang Wang, Jian Chen, et al.
JAMA Cardiology|September 10, 2025
Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart FailureFrederick L Ruberg, Sergio Teruya, Stephen Helmke, et al.
JAMA Cardiology|August 18, 2021
Association of Atrial Fibrillation Burden With Health-Related Quality of Life After Atrial Fibrillation Ablation: Substudy of the Cryoballoon vs Contact-Force Atrial Fibrillation Ablation (CIRCA-DOSE) Randomized Clinical TrialMichelle Samuel, Paul Khairy, Jean Champagne, et al.
Pageof 131